Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 1832

1.

AT1R-AT2R-RXFP1 Functional Crosstalk in Myofibroblasts: Impact on the Therapeutic Targeting of Renal and Cardiac Fibrosis.

Chow BSM, Kocan M, Shen M, Wang Y, Han L, Chew JY, Wang C, Bosnyak S, Mirabito-Colafella KM, Barsha G, Wigg B, Johnstone EKM, Hossain MA, Pfleger KDG, Denton KM, Widdop RE, Summers RJ, Bathgate RAD, Hewitson TD, Samuel CS.

J Am Soc Nephrol. 2019 Sep 11. pii: ASN.2019060597. doi: 10.1681/ASN.2019060597. [Epub ahead of print]

PMID:
31511361
2.

Imbalance of the renin-angiotensin system may contribute to inflammation and fibrosis in IBD: a novel therapeutic target?

Garg M, Royce SG, Tikellis C, Shallue C, Batu D, Velkoska E, Burrell LM, Patel SK, Beswick L, Jackson A, Britto K, Lukies M, Sluka P, Wardan H, Hirokawa Y, Tan CW, Faux M, Burgess AW, Hosking P, Monagle S, Thomas M, Gibson PR, Lubel J.

Gut. 2019 Aug 13. pii: gutjnl-2019-318512. doi: 10.1136/gutjnl-2019-318512. [Epub ahead of print]

PMID:
31409604
3.

Transfer of Candesartan Into Human Breast Milk.

Coberger ED, Jensen BP, Dalrymple JM.

Obstet Gynecol. 2019 Sep;134(3):481-484. doi: 10.1097/AOG.0000000000003446.

PMID:
31403599
4.

The place of ARBs in heart failure therapy: is aldosterone suppression the key?

Markan U, Pasupuleti S, Pollard CM, Perez A, Aukszi B, Lymperopoulos A.

Ther Adv Cardiovasc Dis. 2019 Jan-Dec;13:1753944719868134. doi: 10.1177/1753944719868134. Review.

5.

The Anti-inflammatory Compound Candesartan Cilexetil Improves Neurological Outcomes in a Mouse Model of Neonatal Hypoxia.

Quinlan S, Merino-Serrais P, Di Grande A, Dussmann H, Prehn JHM, Ní Chonghaile T, Henshall DC, Jimenez-Mateos EM.

Front Immunol. 2019 Jul 24;10:1752. doi: 10.3389/fimmu.2019.01752. eCollection 2019.

6.

Effects of angiotensin-II on brain endothelial cell permeability via PPARalpha regulation of para- and trans-cellular pathways.

Guo S, Som AT, Arai K, Lo EH.

Brain Res. 2019 Jul 26;1722:146353. doi: 10.1016/j.brainres.2019.146353. [Epub ahead of print] Review.

PMID:
31356784
7.

Evaluation of gender difference in pharmacokinetics of Candesartan cilexetil in the fasted state by RP-HPLC: A single dose comparative study.

Nawaz HA, Masood MI, Abbas M, Usman M, Khan AM, Rasheed H, Riffat S.

Pak J Pharm Sci. 2019 May;32(3):1019-1024.

PMID:
31278715
8.
9.

Role of Renin-Angiotensin-System in Human Breast Cancer Cells: Is There a Difference in Regulation of Angiogenesis between Hormone-Receptor Positive and Negative Breast Cancer Cells?

Herr D, Sauer C, Holzheu I, Sauter R, Janni W, Wöckel A, Wulff C.

Geburtshilfe Frauenheilkd. 2019 Jun;79(6):626-634. doi: 10.1055/a-0887-7313. Epub 2019 Jun 14.

10.

Effects of Candesartan in the Acute Phase of Intracerebral Hemorrhage.

Jusufovic M, Berge TE, Guo R, You S, Delcourt C, Anderson C, Bath PM, Karlson BW, Berge E, Sandset EC; Scandinavian Candesartan Acute Stroke Trial (SCAST) Study Group.

J Stroke Cerebrovasc Dis. 2019 Aug;28(8):2262-2267. doi: 10.1016/j.jstrokecerebrovasdis.2019.05.010. Epub 2019 Jun 6.

PMID:
31178359
11.

Expanded table: Some drugs for HFrEF.

[No authors listed]

Med Lett Drugs Ther. 2019 Apr 8;61(1569):e57-e62. No abstract available.

PMID:
31169798
12.

Drugs for chronic heart failure.

[No authors listed]

Med Lett Drugs Ther. 2019 Apr 8;61(1569):49-54. No abstract available.

PMID:
31169796
13.

Angiotensin II Receptor 1 Blockage Limits Brain Damage and Improves Functional Outcome After Brain Injury in Aged Animals Despite Age-Dependent Reduction in AT1 Expression.

Timaru-Kast R, Gotthardt P, Luh C, Huang C, Hummel R, Schäfer MKE, Thal SC.

Front Aging Neurosci. 2019 Apr 26;11:63. doi: 10.3389/fnagi.2019.00063. eCollection 2019.

14.

Suppressive effects of type I angiotensin receptor antagonists, candesartan and irbesartan on allergic asthma.

Kim MJ, Im DS.

Eur J Pharmacol. 2019 Jun 5;852:25-33. doi: 10.1016/j.ejphar.2019.02.035. Epub 2019 Feb 21.

PMID:
30797786
15.

Simultaneous transient global amnesia and Takotsubo syndrome after death of a relative: a case report.

Finsterer J, Stollberger C.

J Med Case Rep. 2019 Jan 25;13(1):22. doi: 10.1186/s13256-018-1928-0.

16.

Comparison of Candesartan and Angiotensin-(1-7) Combination to Mito-TEMPO Treatment for Normalizing Blood Pressure and Sympathovagal Balance in (mREN2)27 Rats.

Nautiyal M, Shaltout HA, Chappell MC, Diz DI.

J Cardiovasc Pharmacol. 2019 Mar;73(3):143-148. doi: 10.1097/FJC.0000000000000645.

PMID:
30540685
17.

The impact of generics and generic reference pricing on candesartan and rosuvastatin utilisation, price and expenditure in South Africa.

de Jager H, Suleman F.

Int J Clin Pharm. 2019 Feb;41(1):81-87. doi: 10.1007/s11096-018-0758-x. Epub 2018 Nov 26.

18.

Combination therapy for ischemic stroke: Novel approaches to lengthen therapeutic window of tissue plasminogen activator.

Knecht T, Borlongan C, Dela Peña I.

Brain Circ. 2018 Jul-Sep;4(3):99-108. doi: 10.4103/bc.bc_21_18. Epub 2018 Oct 9. Review.

19.

Clinical Inquiries. How effectively do ACE inhibitors and ARBs prevent migraines?

Morris B, Neher J, Safranek S.

J Fam Pract. 2018 Oct;67(10):652-654. Review. No abstract available.

PMID:
30423002
20.

Pleiotropic Benefits of the Angiotensin Receptor Blocker Candesartan in a Mouse Model of Alzheimer Disease.

Trigiani LJ, Royea J, Lacalle-Aurioles M, Tong XK, Hamel E.

Hypertension. 2018 Nov;72(5):1217-1226. doi: 10.1161/HYPERTENSIONAHA.118.11775.

PMID:
30354809

Supplemental Content

Loading ...
Support Center